Catalyst Wire Dossier Catalyst Wire Dossier

CS060380 Tablets

CS060380 · Cascade Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CS060380 Tablets, covering 2026-03-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CS060380 Tablets in Patients With MASH and Obesity [Phase 2]

See pricing